Related Experiment Videos

[A case of myocardial infarction in a young man with systemic lupus erythematosus]

Y Asakura1, S Nakamoto, Y Nishikawa

  • 1Department of Internal Medicine, School of Medicine, Keio University.

Kokyu to Junkan. Respiration & Circulation
|May 1, 1992
PubMed

Insights

Systemic lupus erythematosus (SLE) can cause acute myocardial infarction in young adults due to coronary artery thrombosis, not atherosclerosis. Anticardiolipin antibodies likely contribute to this rare but serious complication in SLE patients.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Coronary artery disease (CAD) incidence is rising in systemic lupus erythematosus (SLE) patients, often linked to corticosteroid treatment and atherosclerosis.
  • Acute myocardial infarction (AMI) is uncommon in young, untreated SLE patients without traditional risk factors.

Observation:

  • A 21-year-old male with latent, untreated SLE experienced AMI.
  • Coronary arteriography revealed a transient proximal right coronary artery stenosis.
  • The patient had no conventional coronary risk factors but presented with SLE markers and lymphocytopenia.

Findings:

  • The transient coronary stenosis was attributed to thrombus formation, excluding atherosclerosis, arteritis, or embolus.
  • Laboratory results confirmed SLE, including positive antinuclear antibody and LE cell tests.
  • Elevated antibodies to cardiolipin were detected, suggesting a thrombogenic role.

Implications:

  • This case highlights a potential mechanism for AMI in SLE via anticardiolipin antibody-mediated coronary thrombosis.
  • It underscores the importance of considering thrombotic events in young SLE patients presenting with cardiac symptoms.
  • Further research into the role of antiphospholipid antibodies in SLE-related cardiovascular complications is warranted.

Related Concept Videos